CStone Pharmaceuticals(HK:2616)
HK$5.68-0.33 (-5.41%)
HK:2616
CStone Pharmaceuticals financials statements
HK$5.68
At close:-0.33 (-5.41%)
Want to see HK:2616 full AI Analyst Report?
CStone Pharmaceuticals (2616) Income Statement
5 Followers
CStone Pharmaceuticals Income Statement
Last quarter (Q2 2026), CStone Pharmaceuticals's total revenue was ¥202.27M, a decrease of 20.42% from the same quarter last year. In Q2, CStone Pharmaceuticals's net income was ¥-248.80M. See CStone Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 269.58M | ¥ 407.20M | ¥ 463.84M | ¥ 481.36M | ¥ 243.72M | |
| ¥ 51.25M | ¥ 240.15M | ¥ 304.30M | ¥ 278.38M | ¥ 136.89M | |
| ¥ 483.87M | ¥ 331.85M | ¥ 909.86M | ¥ 1.19B | ¥ 1.97B | |
| Depreciation and Amortization | ¥ 43.98M | ¥ 49.80M | ¥ 58.19M | ¥ 44.54M | ¥ 22.66M |
| ¥ -371.84M | ¥ -45.55M | ¥ -297.23M | ¥ -849.66M | ¥ -1.90B | |
| ¥ -432.62M | ¥ -91.69M | ¥ -605.57M | ¥ -912.15M | ¥ -1.83B | |
| ¥ 8.68M | ¥ 485.00K | ¥ 238.33M | ¥ 9.47M | ¥ -90.66M | |
| ¥ -423.94M | ¥ -91.21M | ¥ -367.23M | ¥ -902.68M | ¥ -1.92B | |
| ¥ -437.00M | ¥ -91.21M | ¥ -367.23M | ¥ -902.68M | ¥ -1.92B | |
| Per Share Metrics | |||||
| Basic EPS | ¥ -0.31 | ¥ -0.07 | ¥ -0.29 | ¥ -0.77 | ¥ -1.65 |
| Diluted EPS | ¥ -0.31 | ¥ -0.07 | ¥ -0.29 | ¥ -0.77 | ¥ -1.65 |
| Weighted Average Shares Outstanding | 1.39B | 1.28B | 1.26B | 1.17B | 1.16B |
| Weighted Average Shares Outstanding (Diluted) | 1.39B | 1.28B | 1.26B | 1.17B | 1.17B |
Currency in CNY

